The latest advances in liquid biopsy and immunotherapy promise to revolutionize the way cancer is detected, treated, and cured—yet the hurdles to realizing their benefits are both technical and systemic. This panel will discuss major investments, emerging companies, and novel discoveries in cancer, and their impact on patient care. Leveraging the perspective of investors, entrepreneurs, and patients, we'll investigate how we can accelerate science and the rate at which advances are translated into patient impact.

Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.